Rabeprazole

Rabeprazole tablets are indicated for the treatment of: • Active duodenal ulcer • Active benign gastric ulcer • Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD). • Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance) • Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD) • Zollinger-Ellison Syndrome • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori (H.

pylori) in patients with peptic ulcer disease. 2.

1 ). 2 ). 3 ). 4 ). 5 ). 6 ). 7 ). 1 Healing of Erosive or Ulcerative GERD in Adults Rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).

For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium delayed-release tablets may be considered. 2 Maintenance of Healing of Erosive or Ulcerative GERD in Adults Rabeprazole sodium delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (GERD Maintenance).

Controlled studies do not extend beyond 12 months. 3 Treatment of Symptomatic GERD in Adults Rabeprazole sodium delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with GERD in adults for up to 4 weeks.

RABEPRAZOLE EC (rabeprazole sodium) is indicated for treatment of conditions where a reduction of gastric acid secretion is required, such as: • Symptomatic relief and healing of erosive or ulcerative gastroesophageal reflux disease (GERD).

• Long-term maintenance of healing of erosive or ulcerative gastroesophageal reflux disease (GERD). , heartburn and regurgitation) in symptomatic gastroesophageal reflux disease (GERD), also called non-erosive reflux disease (NERD).

• Symptomatic relief and healing of duodenal ulcers. • Symptomatic relief and healing of gastric ulcers. • Long-term treatment of pathological hypersecretory conditions, including Zollinger- Ellison syndrome. • Eradication of Helicobacter pylori (H.

pylori) associated with duodenal ulcer disease (active or history within the past 5 years). Rabeprazole, in combination with appropriate antibacterial therapeutic regimens such as amoxicillin and clarithromycin, is indicated for the treatment of patients with duodenal ulcer disease associated with H.